Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 311

1.

Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.

Choi JY, Lee KM, Park SK, Noh DY, Ahn SH, Chung HW, Han W, Kim JS, Shin SG, Jang IJ, Yoo KY, Hirvonen A, Kang D.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1090-5.

2.

SULT1E1 genetic polymorphisms modified the association between phytoestrogen consumption and bone mineral density in healthy Korean women.

Lee SA, Choi JY, Shin CS, Hong YC, Chung H, Kang D.

Calcif Tissue Int. 2006 Sep;79(3):152-9. Epub 2006 Sep 11.

PMID:
16969590
3.

Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.

Lee KM, Choi JY, Park SK, Chung HW, Ahn B, Yoo KY, Han W, Noh DY, Ahn SH, Kim H, Wei Q, Kang D.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):821-5.

4.

A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.

Han W, Kang D, Lee JE, Park IA, Choi JY, Lee KM, Bae JY, Kim S, Shin ES, Lee JE, Shin HJ, Kim SW, Kim SW, Noh DY.

Clin Cancer Res. 2005 Jul 1;11(13):4775-8.

5.

Genetic polymorphisms of the CYP19A1 gene and breast cancer survival.

Long JR, Kataoka N, Shu XO, Wen W, Gao YT, Cai Q, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2115-22.

6.

CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk.

Han S, Lee KM, Choi JY, Park SK, Lee JY, Lee JE, Noh DY, Ahn SH, Han W, Kim DH, Hong YC, Ha E, Yoo KY, Kang D.

Breast Cancer Res Treat. 2008 Jul;110(2):387-93. Epub 2007 Oct 17.

PMID:
17940865
7.

Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women.

Lee KM, Park SK, Hamajima N, Tajima K, Choi JY, Noh DY, Ahn SH, Yoo KY, Hirvonen A, Kang D.

Breast Cancer Res Treat. 2006 Mar;96(2):197-202. Epub 2005 Nov 30.

PMID:
16319982
8.

Genetic polymorphisms of TGF-beta1 & TNF-beta and breast cancer risk.

Lee KM, Park SK, Hamajima N, Tajima K, Yoo KY, Shin A, Noh DY, Ahn SH, Hirvonen A, Kang D.

Breast Cancer Res Treat. 2005 Mar;90(2):149-55.

PMID:
15803361
9.

A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.

Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP.

Breast Cancer Res Treat. 2007 Jan;101(1):73-81. Epub 2006 Jun 29. Erratum in: Breast Cancer Res Treat. 2007 Apr;102(2):249.

PMID:
16807674
10.

Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.

Kataoka N, Cai Q, Wen W, Shu XO, Jin F, Gao YT, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1148-52.

11.

Megsin 2093T-2180C haplotype at the 3' untranslated region is associated with poor renal survival in Korean IgA nephropathy patients.

Lim CS, Kim SM, Oh YK, Joo KW, Kim YS, Han JS, Kim S.

Clin Nephrol. 2008 Aug;70(2):101-9.

PMID:
18793525
12.

Interleukin-12 p40 gene (IL12B) polymorphisms and the risk of cervical cancer in Korean women.

Han SS, Cho EY, Lee TS, Kim JW, Park NH, Song YS, Kim JG, Lee HP, Kang SB.

Eur J Obstet Gynecol Reprod Biol. 2008 Sep;140(1):71-5. doi: 10.1016/j.ejogrb.2008.02.007. Epub 2008 Mar 25.

PMID:
18367309
13.

Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women <or=55 years.

Lu J, Wei Q, Bondy ML, Li D, Brewster A, Shete S, Yu TK, Sahin A, Meric-Bernstam F, Hunt KK, Singletary SE, Ross MI, Wang LE.

Carcinogenesis. 2006 Nov;27(11):2209-16. Epub 2006 May 19.

PMID:
16714331
14.

Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study.

Deming SL, Ren Z, Wen W, Shu XO, Cai Q, Gao YT, Zheng W.

Breast Cancer Res Treat. 2007 Sep;104(3):309-19. Epub 2006 Oct 25.

PMID:
17063263
15.

Caspase 9 promoter polymorphisms and risk of primary lung cancer.

Park JY, Park JM, Jang JS, Choi JE, Kim KM, Cha SI, Kim CH, Kang YM, Lee WK, Kam S, Park RW, Kim IS, Lee JT, Jung TH.

Hum Mol Genet. 2006 Jun 15;15(12):1963-71. Epub 2006 May 10.

PMID:
16687442
16.

Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India.

Sreeja L, Syamala VS, Syamala V, Hariharan S, Raveendran PB, Vijayalekshmi RV, Madhavan J, Ankathil R.

J Cancer Res Clin Oncol. 2008 Jun;134(6):645-52. Epub 2007 Oct 19.

PMID:
17952468
17.

Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population.

Kohaar I, Tiwari P, Kumar R, Nasare V, Thakur N, Das BC, Bharadwaj M.

Breast Cancer Res Treat. 2009 Mar;114(2):347-55. doi: 10.1007/s10549-008-0006-5. Epub 2008 Apr 14.

PMID:
18409070
18.

Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians.

Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R, Bhatnagar D, Bhatnagar A, Chintamani C, Sharma PC, Saxena S.

Cancer Detect Prev. 2009;32(5-6):386-94.

PMID:
19588543
19.

Variants in DNA double-strand break repair genes and breast cancer susceptibility.

Kuschel B, Auranen A, McBride S, Novik KL, Antoniou A, Lipscombe JM, Day NE, Easton DF, Ponder BA, Pharoah PD, Dunning A.

Hum Mol Genet. 2002 Jun 1;11(12):1399-407.

PMID:
12023982
20.

Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort.

Freedman ML, Penney KL, Stram DO, Le Marchand L, Hirschhorn JN, Kolonel LN, Altshuler D, Henderson BE, Haiman CA.

Hum Mol Genet. 2004 Oct 15;13(20):2431-41. Epub 2004 Aug 18.

PMID:
15317758

Supplemental Content

Support Center